Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.
Símbolo de cotizaciónEKSO
Nombre de la empresaEkso Bionics Holdings Inc
Fecha de salida a bolsaApr 10, 2013
Director ejecutivoMr. Scott G. Davis
Número de empleados61
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 10
Dirección101 Glacier Point
CiudadSAN RAFAEL
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal94901
Teléfono15109841761
Sitio Webhttps://eksobionics.com/
Símbolo de cotizaciónEKSO
Fecha de salida a bolsaApr 10, 2013
Director ejecutivoMr. Scott G. Davis
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos